Trial Profile
A study comparing 18f-Florbetaben quantification results using MR based and MR less CapAIBL and validation against histopathology.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2017
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease; Amyloidosis
- Focus Diagnostic use
- 23 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017